SAVA
Cassava Sciences Inc
NASDAQ: SAVA · HEALTHCARE · BIOTECHNOLOGY
$1.45
+0.69% today
Updated 2026-04-30
Market cap
$142.03M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-2.22
Dividend yield
—
52W range
$1 – $5
Volume
0.5M
Cassava Sciences Inc (SAVA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |